文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

炎症细胞因子在类风湿关节炎和动脉粥样硬化发生中的作用:综述

Role of Inflammatory Cytokines in Rheumatoid Arthritis and Development of Atherosclerosis: A Review.

作者信息

Bedeković Dražen, Bošnjak Ivica, Šarić Sandra, Kirner Damir, Novak Srđan

机构信息

Department of Cardiovascular Diseases Internal Medicine Clinic, University Hospital Osijek, J. Huttlera 4, 31000 Osijek, Croatia.

Faculty of Medicine Osijek, Department of Internal Medicine, Josip Juraj Strossmayer University, J. Huttlera 4, 31000 Osijek, Croatia.

出版信息

Medicina (Kaunas). 2023 Aug 26;59(9):1550. doi: 10.3390/medicina59091550.


DOI:10.3390/medicina59091550
PMID:37763669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10534747/
Abstract

Uncontrolled chronic inflammation results in cardiovascular disease and early death. In this review, we studied the impact of rheumatoid arthritis on the cardiovascular system, including the early and accelerated development of atherosclerosis and its clinical manifestations, focusing on the inflammatory mechanisms leading to arterial wall damage, rapid atherosclerotic plaque formation, and thrombosis. Furthermore, the effect of medications used to treat rheumatoid arthritis on the cardiovascular system was studied. The effect of chronic inflammation and medication on traditional cardiovascular risk factors is not the main subject of this review. We observed that uncontrolled chronic inflammation and some medications directly impact all the stages of atherosclerosis. In conclusion, reducing inflammation and maintaining long-term remission in rheumatoid arthritis may prevent early atherosclerosis. We believe that this review will encourage a better interdisciplinary approach to the management of these patients and further research in this field.

摘要

不受控制的慢性炎症会导致心血管疾病和过早死亡。在本综述中,我们研究了类风湿性关节炎对心血管系统的影响,包括动脉粥样硬化的早期和加速发展及其临床表现,重点关注导致动脉壁损伤、快速动脉粥样硬化斑块形成和血栓形成的炎症机制。此外,还研究了用于治疗类风湿性关节炎的药物对心血管系统的影响。慢性炎症和药物对传统心血管危险因素的影响并非本综述的主要主题。我们观察到,不受控制的慢性炎症和一些药物会直接影响动脉粥样硬化的所有阶段。总之,减轻类风湿性关节炎中的炎症并维持长期缓解可能会预防早期动脉粥样硬化。我们相信,本综述将鼓励采用更好的跨学科方法来管理这些患者,并推动该领域的进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2648/10534747/fdcd691a5e25/medicina-59-01550-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2648/10534747/14d15702eaf1/medicina-59-01550-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2648/10534747/fdcd691a5e25/medicina-59-01550-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2648/10534747/14d15702eaf1/medicina-59-01550-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2648/10534747/fdcd691a5e25/medicina-59-01550-g002.jpg

相似文献

[1]
Role of Inflammatory Cytokines in Rheumatoid Arthritis and Development of Atherosclerosis: A Review.

Medicina (Kaunas). 2023-8-26

[2]
Potential effect of anti-inflammatory treatment on reducing the cardiovascular risk in rheumatoid arthritis.

Curr Vasc Pharmacol. 2012-9

[3]
Rheumatoid Arthritis: Atherosclerosis Imaging and Cardiovascular Risk Assessment Using Machine and Deep Learning-Based Tissue Characterization.

Curr Atheroscler Rep. 2019-1-25

[4]
Methotrexate, blood pressure and arterial function in rheumatoid arthritis: study protocol.

Future Cardiol. 2024

[5]
Periodontal Disease as a Risk Factor for Rheumatoid Arthritis: A Systematic Review.

JBI Libr Syst Rev. 2012

[6]
[Atherosclerosis and rheumatoid arthritis].

Przegl Lek. 2005

[7]
New insights to the mechanisms underlying atherosclerosis in rheumatoid arthritis.

Int J Rheum Dis. 2017-3

[8]
Atherosclerosis in rheumatoid arthritis: is it all about inflammation?

Nat Rev Rheumatol. 2015-3-31

[9]
How early is the atherosclerotic risk in rheumatoid arthritis?

Autoimmun Rev. 2010-6-11

[10]
An update on the relationships between rheumatoid arthritis and atherosclerosis.

Atherosclerosis. 2010-4-4

引用本文的文献

[1]
Healthcare Interventions in the Management of Rheumatic Diseases: A Narrative Analysis of Effectiveness and Emerging Strategies.

Healthcare (Basel). 2025-7-14

[2]
The Inflammatory Link of Rheumatoid Arthritis and Thrombosis: Pathogenic Molecular Circuits and Treatment Approaches.

Curr Issues Mol Biol. 2025-4-18

[3]
Low adherence to cardiovascular risk assessment guidelines in patients with rheumatoid arthritis: a retrospective chart review of routine clinical practice.

Rheumatol Int. 2025-6-26

[4]
Where Do We Stand in the Management of Rheumatoid Arthritis Ahead of EULAR/ACR 2025?

Clin Pract. 2025-5-28

[5]
Targeting Aging Hallmarks with Monoclonal Antibodies: A New Era in Cancer Immunotherapy and Geriatric Medicine.

Int J Mol Sci. 2025-5-22

[6]
Single-cell multi-omics reveals the TNF-α activation threshold for Classical Monocytes by studying healthy donors and rheumatoid arthritis patients.

Front Immunol. 2025-5-16

[7]
miR-6089 may prevent the inflammatory events leading to cardiovascular disorders in RA patients.

Heliyon. 2024-8-23

[8]
Emerging Landscape of Models for Assessing Rheumatoid Arthritis Management.

ACS Pharmacol Transl Sci. 2024-7-18

[9]
Treating Cardiovascular Disease in the Inflammatory Setting of Rheumatoid Arthritis: An Ongoing Challenge.

Biomedicines. 2024-7-19

[10]
A Review of Advances in Molecular Imaging of Rheumatoid Arthritis: From In Vitro to Clinic Applications Using Radiolabeled Targeting Vectors with Technetium-99m.

Life (Basel). 2024-6-12

本文引用的文献

[1]
Interleukin 6 as a marker of severe bacterial infection in children with sickle cell disease and fever: a case-control study.

BMC Infect Dis. 2021-8-3

[2]
Serum Tumor Necrosis Factor-Alpha as a Competent Biomarker for Evaluation of Disease Activity in Early Rheumatoid Arthritis.

Cureus. 2021-5-29

[3]
Images in Vascular Medicine: Successful endovascular treatment of psoriasis-induced critical limb ischemia.

Vasc Med. 2021-6

[4]
Effect of statin use on the risk of rheumatoid arthritis: A systematic review and meta-analysis.

Semin Arthritis Rheum. 2020-12

[5]
Association between biologic disease modifying anti-rheumatic drugs and incident hypertension in patients with rheumatoid arthritis: Results from prospective nationwide KOBIO Registry.

Medicine (Baltimore). 2020-2

[6]
Incidence and effect of insulin resistance on progression of atherosclerosis in rheumatoid arthritis patients of long disease duration.

Biomed J. 2019-11-7

[7]
Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE/APLAR/APSDE/APSH/APSN/PoA recommendations.

Gut. 2020-1-14

[8]
Autoimmunity and Inflammation Link to Cardiovascular Disease Risk in Rheumatoid Arthritis.

Rheumatol Ther. 2020-3

[9]
Platelet indices in patients with chronic inflammatory arthritis: a systematic review and meta-analysis.

Platelets. 2020-10-2

[10]
Impact of Cumulative Inflammation, Cardiac Risk Factors, and Medication Exposure on Coronary Atherosclerosis Progression in Rheumatoid Arthritis.

Arthritis Rheumatol. 2020-1-22

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索